.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=oU~6rvvw4rfR6rzdlaKTlj5yPiC4qrTVeLEQFrAJ3FZCPanoSU9ECej7wO4yAfRFXlRBsVAocFOIS47cg~4wgM1lr3~uhK0r6KEOkSq1RVssSetFdWCpKTV54naNo-4HaVpz6vVuXC6VUPu17UPO6n~RX20y6YV0uPEZYj6GXsBz7FxEf6P1W20Kof2YcjhQfmP93dL2I9iHt-TIRIb1BeAh43X~zqXW-A4bFmT0IEoR9~Ugv3kcrW4nLamf8yKL4KwNh-KNxJNLCAhuVjK2SGmbpgheCIMh~rTCxAU7DTCyrAQaMxmle9XrWMDsCai6LJPCZnsS~RJdLp1AnE4NZA__)
TRU.HYAL 100™ 나이트 리페어 캡슐 광고 디자인
포트폴리오 설명
TRU.HYAL 100™ 나이트 리페어 캡슐 광고 디자인입니다. 이 제품은 로레알 특허 성분을 함유하여 강력한 리프팅 및 타이트닝 효과를 제공하며, 마스크팩 100장의 효과를 캡슐 하나로 경험할 수 있습니다. 주요 디자인 특징은 다음과 같습니다. 1. **모델 활용**: 깨끗하고 건강한 피부를 가진 모델을 사용하여 제품의 효능을 시각적으로 강조했습니다. 2. **리프팅 효과 강조**: 이마, 눈가, 팔자, 입가 리프팅 효과를 수치화하여 제품의 효능을 명확하게 전달합니다. 3. **주요 성분 부각**: 로레알 특허 성분, PDRN, 스쿠알란 등 주요 성분을 강조하여 제품의 신뢰도를 높입니다. 4. **사용 전후 비교**: 제품 사용 전후의 피부 변화를 시각적으로 비교하여 효능을 극대화합니다. 5. **시크릿 특가 페이지 안내**: 한정 수량 시크릿 페이지 오픈을 강조하여 고객의 구매를 유도합니다. 이 디자인은 제품의 효능을 명확하게 전달하고, 고객의 구매 욕구를 자극하는 데 중점을 두었습니다.
카테고리
패키지 디자인
태그
뷰티 브랜드
패키지 디자인
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=oU~6rvvw4rfR6rzdlaKTlj5yPiC4qrTVeLEQFrAJ3FZCPanoSU9ECej7wO4yAfRFXlRBsVAocFOIS47cg~4wgM1lr3~uhK0r6KEOkSq1RVssSetFdWCpKTV54naNo-4HaVpz6vVuXC6VUPu17UPO6n~RX20y6YV0uPEZYj6GXsBz7FxEf6P1W20Kof2YcjhQfmP93dL2I9iHt-TIRIb1BeAh43X~zqXW-A4bFmT0IEoR9~Ugv3kcrW4nLamf8yKL4KwNh-KNxJNLCAhuVjK2SGmbpgheCIMh~rTCxAU7DTCyrAQaMxmle9XrWMDsCai6LJPCZnsS~RJdLp1AnE4NZA__)
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=i4T0EKBzb2pr-edQ89CoAYlXm2Q2Ja9uKsJHUFFUfMfB4Pe6jnYT2SsPx614FLzZrVA8VAtdyAPNj76tNMxw-Nv8UZ9TCiDJYjmM3sECm5J2kS3q5r~XO7RjbSTjGDQe5YtxGsEFMnHaCt-f~EVrXjohxQmgSQuO6JtaY04U~OmJazup3Zx10YO7sSZ6msHy0HGdtnncyqJLcnbSrhkmiZq2gSOHVqrhTOTMNzOIYsHPGGRgzkJ~P06mZ~Ci0EQaibLkVJ-a0GdIOs-lVJwk1Gt98U2fCJpVKtEfbExWP6IlyrViwBqIPdG-eVlTd7Xv3hcNSMgFxiej795VbWlpvQ__)
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=658i45ZD5QfJAsOZppB2o~cGh6kTsRo8axYoq~ebg4~lb3jaDcDSU3DM9LbwS5dMDlTN~JZf1Yc~zhdcas4Af2nTJnpCxQm8syNhR99qofIeO8T-TTj2wSuBN9QRKR~QR2BjjtU7JMnlehIuZAlX0C-7m4CjFtC-jTT5bjV4~2jll6GinHf~ToQ2YdLMACAxvKgWUbUPbNQkHfDYMr1wlmGJXQgdra4he186piBzZQ3E5V1axLaNhQQofp1UGCIwFQrMGpQS6a1cDoQzMqh6sfQbpURmrCPfIYOazG5WV0leeJDTUBOUy2Y04eTv9XfY8xjGUC99GS-j~9CzD814lQ__)
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=x-CcpbLZNIzY5Wh2hYtqZ7JvQ8ztevAIzJVK7KKMJQtOquGWYhorIFa3teXXJp-xf7bfthpyZKX-rs1YhrRQROXXnJmt7u5BhmECi7JTbeyFbB0Dd0CaUD~4p8BgdzUCJSEg1hVu7lYQzW8BljL6C47D1dPjUA-EegPxkfpsOXmClg6Wtr7N0zqq32fknRZ7B1HCTqOJP8RV4V-q7ZjRl9dI9B2B-28aSrSOKZIfdIBugzW1KWbrbss0vyh~DMBPYl3m9FRzDlDQdhhpgtuyZ2uNcvRD5~REWZYx9SUS9HEVlReGMsS~pkJv5s8J-OTQ2Q5kqSFsvHBxJk~EfK4ZBQ__)
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=Y4nKEvR6YYgQAy8QeFPRn9wsQjJAxUy7Bn2-bPRbrPH3kn90iup9bhHl2D87i6Jq6rbF0AX8aFRlWqJZNd8o70PTRgx2bEGf58Jiv5G2UJVVh7P6Vz88Omq6ezfibsd3iCe-ComcK~hIK3A4HS~TbhjeVkmHYklCFvN63wsU1X2awsEBKXEL~Wnq6g9z-ZV4Ci8idILv2OPUvNqUiam3e716Osph5ROBhm3yddvLWIWlE0BkTjBURlTXeS5Llwbn-~nj7jDFVr5dqjcPNicBtratrbEXZsnmksYR6vWrpgJfBzrsBzoHSSLG6CXtPRAnVB9hkQWHSGzTscqQ8xFw9g__)
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=6YvkNs8SehMEn~JsmukvTk5wr6SALT-jvoUWahGlKFf~RiMHlCLjn-MMcnFXIGQHdDTHnhfZBvld9z-aCdy~8ok8CFrBALoo1EjZHiHM4RanRQa-lpniwoII3IiduO3GuQKCNtWUSKnuQ3dlryc03IwY~SB28H9xyc5RSj9xS1xqpFHGmW8zop2~Q~A9rQ36Yf11U2FwZ17HrFRD0lGDF7QKQ5Yz2LfQq9K~QADT3S2mewdxJrV-p2Lg~xlxt1YC0kc9U6UJ015odv~Ouzw7O6R9jhSNLI-rVR8Qg2IcZ1kBI1fjJ2MF6UtzQBZq9TrB5cUidqfN5l8~1BkB~Wz0Sg__)
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=ufUjY5OF3sNN6qPcPsPUPE~yidOj7moaNpRLx7fOknzObnWPVJbPSHJXsYTLvBhNLtF4Q0-Ixa8SbcSNtU1alwygvpV935FURWLbc7DmJQVIDYqxIazMDF9W4UDJAIR6c2f3K9bj4xU6tgfxEbpqVozVDF87DSP8MtF0pENYjKtapWVxet1ySAde3SyaB67FAKQkbUuXCYWaqZtXPyXC3YN9TpdPG0mbGnWU1XChcIPH0eiQHyq05IVOaJMfVQX1WYZNVHQwOltp856UhhH3BwlomOGwLETR5EFNn0N2DwX~q6MC7aXlv-qXWjGHpo-o3D95TiELYCHNAiRDeUmJSg__)
.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=9QoG~pzXktd5iNqH5OdSN4C0CkXDU3VmAC9rOtaT~l1sPFf23IoTVr6c5yT9aub9aXWjvpwG-S9i~xKuCNRc3qCGDZCoQQGA44Lj9xAxMrMifJul~-wK4zLTlhFpRadXJGZqtgbbZ0Atcnmo4ci3TpKaLv15yCgqDtze~622AG71RQRE8l2-c5TgFXhDc53f1t3JXM6zhB7-KeC-wYJHoR3A-Qdlmc4905QDdOqL~cHce8ZQ5HcQSId-8CizbKGWrwhX7gNogS2wmoMNmjVlXm11tMgG3fmQ5zJj4GCPQsbTRHvZG9bcYnjTPsWuO9lnYrd6G-2q372CJ5YXmwtR2Q__)
og.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=z7-3KhsEi2-zHkSvaj~bKbw4ft6UcosmlBJNdW8Vu6~9XyfHly~TGkfPzD3IXIYIh7eO~rCabRPbmBDfiJqhokqheFjB659qx7pq2JokZCjZ9YomKsN1D1Ht0k1Igu3NYU00m5P1R8iiFHH9-pQxSMw-tbCLoKbsPrbg3WlxUosQyzchcLbBFjbP~SF7Cjg6LCz6lt5Qx4vKJgE1v4h592hbmpC7VQzi~KMLBeQ-ESiit6MO5FG6oLtn2JUBwOE~9WDMUsZVWugi2x53OiMzkx8vmnf0lTphwDFopp0bnNrxVsINFdHS2W1ertoJoQE-k5CDnkGt12ITvcN60nsHSA__)
og.jpg?Expires=10413792000&Key-Pair-Id=K5RA2VBHFYRMG&Signature=yjMVVRjqJ2m1ZJRwOYR~aX8PuldzSIRoZmlYLVegiLMXCtkQmaH6qWcI7VLtFmeMgBjdb5TxXMqMP-zEGvZBbQJNZRUPcHWxmVX7R41y5yMP12nYJWWk9EsAGfaxrHSd4g8bIIh6qqIeb-KnFFLs-Px6zmo80FrbMnMaWB-JxyBYNx~qUFsqCcSglDZyQqbl3U~mUKds9hLnk1TSEfFaN5urcCMTSZX72dIBuHx8V6Uz3A4sOLMcPh2oUT-Fg3bBlWmJ9nQQmm7wZc2itj-QOREqvkJT5Zk6FqiURTUdzfEIyIh~vu3jx1-0BmEecbwbtNOg2Ll-tGzQIh53g~3v1A__)